{"id":937885,"date":"2026-02-18T08:40:18","date_gmt":"2026-02-18T13:40:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/"},"modified":"2026-02-18T08:40:18","modified_gmt":"2026-02-18T13:40:18","slug":"immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/","title":{"rendered":"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025"},"content":{"rendered":"

\nConference Call Scheduled for Thursday, March 5, 2026 at 9:00 AM ET
\n<\/h2>\n
\n

PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) <\/strong>(\u201cImmuCell\u201d or the \u201cCompany\u201d), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, expects to report unaudited financial results for the quarter and year ended December 31, 2025 after the market closes on Wednesday, March 4, 2026.<\/p>\n

The Company is planning to host a conference call the next morning, Thursday, March 5, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET. A teleconference replay of the call will be available until March 12, 2026 at (855) 669-9658 (toll free) or (412) 317-0088 (international), utilizing replay access code #2017737.<\/p>\n

The Company anticipates no change to the preliminary sales results for the quarter and year ended December 31, 2025 that were disclosed on January 8, 2026. The Company expects to file its Annual Report on Form 10-K on or before Tuesday, March 31, 2026.<\/p>\n

\n
\n About ImmuCell:<\/u>
\n <\/strong>
\n
ImmuCell Corporation’s (Nasdaq: ICCC<\/strong>) purpose is to create scientifically proven and practical products that improve cattle health and productivity.\u00a0ImmuCell manufactures and markets First Defense<\/strong>\u00ae<\/sup>, providing Immediate Immunity<\/strong>\u2122 to newborn dairy and beef calves. Press releases and other information about the Company are available at: http:\/\/www.immucell.com<\/u><\/a>.<\/p>\n\n\n\n\n\n\n\n\n\n
\n Contacts:<\/strong>\n <\/td>\nOlivier te Boekhorst, President and CEO<\/td>\n<\/tr>\n
\u00a0<\/td>\nTimothy C. Fiori, Chief Financial Officer<\/td>\n<\/tr>\n
\u00a0<\/td>\nImmuCell Corporation<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n investor.relations@immucell.com<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\nJoe Diaz, Robert Blum and Joe Dorame<\/td>\n<\/tr>\n
\u00a0<\/td>\nLytham Partners, LLC<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n iccc@lythampartners.com<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n
\n
\n <\/strong>\n <\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Conference Call Scheduled for Thursday, March 5, 2026 at 9:00 AM ET PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, expects to report unaudited financial results for the quarter and year ended December 31, 2025 after the market closes on Wednesday, March 4, 2026. The Company is planning to host a conference call the next morning, Thursday, March 5, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET. A teleconference replay of the … <\/p>\n

Continue reading “ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-937885","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference Call Scheduled for Thursday, March 5, 2026 at 9:00 AM ET PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, expects to report unaudited financial results for the quarter and year ended December 31, 2025 after the market closes on Wednesday, March 4, 2026. The Company is planning to host a conference call the next morning, Thursday, March 5, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET. A teleconference replay of the … Continue reading "ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-18T13:40:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025\",\"datePublished\":\"2026-02-18T13:40:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/\",\"name\":\"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=\",\"datePublished\":\"2026-02-18T13:40:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/","og_locale":"en_US","og_type":"article","og_title":"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 - Market Newsdesk","og_description":"Conference Call Scheduled for Thursday, March 5, 2026 at 9:00 AM ET PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, expects to report unaudited financial results for the quarter and year ended December 31, 2025 after the market closes on Wednesday, March 4, 2026. The Company is planning to host a conference call the next morning, Thursday, March 5, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET. A teleconference replay of the … Continue reading \"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-18T13:40:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025","datePublished":"2026-02-18T13:40:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/","name":"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=","datePublished":"2026-02-18T13:40:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjcxNiM3NDMxODU2IzIwODk4MDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/937885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=937885"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/937885\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=937885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=937885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=937885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}